Anika Therapeutics (ANIK) vs SIGA Technologies (SIGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Anika Therapeutics (ANIK) has outperformed SIGA Technologies (SIGA) over the past year, gaining 114.9% versus a loss of 60.4%. Over five years, ANIK leads with a -53.1% price change compared with -53.9% for SIGA. Anika Therapeutics is the larger company by market cap ($257.4 million vs $235.7 million), about 1.1 times the size.
On valuation, SIGA Technologies trades at a lower forward P/E (3.0x vs 20.2x for Anika Therapeutics).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIK | SIGA |
|---|---|---|
| Share price | $19.23 | $3.28 |
| Market cap | $257.35M | $235.67M |
| 1-day change | -1.54% | +0.61% |
| YTD return | +103.23% | -46.32% |
| 1-year return | +114.85% | -60.39% |
| 5-year return | -53.12% | -53.87% |
| Forward P/E | 20.24 | 3.04 |
| EPS (TTM) | $-0.23 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.88 | $8.55 |
| 52-week low | $8.67 | $2.83 |
| Distance from 52-week high | -15.95% | -61.64% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +19.60% | — |
| Average volume | 98.57K | 726.50K |
| Shares outstanding | 13.38M | 71.85M |
| Employees | 235 | 49 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIK has outperformed SIGA by 175.2 percentage points over the past year.
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
About SIGA Technologies
SIGA stock →SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
ANIK vs SIGA FAQ
Which is bigger, Anika Therapeutics or SIGA Technologies?
Anika Therapeutics (ANIK) is larger, with a market capitalization of $257.35M compared with $235.67M for SIGA Technologies (SIGA).
Which stock has performed better over the past year, ANIK or SIGA?
ANIK returned +114.85% over the past 12 months, compared with -60.39% for SIGA (price return, excluding dividends). Past performance does not predict future results.
Are Anika Therapeutics and SIGA Technologies in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Anika Therapeutics and Biotechnology: Pharmaceutical Preparations for SIGA Technologies.